Vineet R. Jindal - Chief Financial Officer at OnKure Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
OKUR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Vineet R. Jindal since 25 Aug 2025

Reported holdings for Vineet R. Jindal in OnKure Therapeutics, Inc.

Form 4 holding Chief Financial Officer

Reneo Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
36,600
Estimated value
$229,691
Report date
10 Dec 2021
Price
$6.28
Ownership
Direct
Form 4 holding Chief Financial Officer

Reneo Pharmaceuticals, Inc.

Security class
Stock option (right to buy)
Shares / value
100,000
Estimated value
Report date
10 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Vineet R. Jindal in OnKure Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .